An Informed and Activated Patient: Addressing Barriers in the Pathway From Education to Outcomes. Wright Nunes JA, Cavanaugh KL, Fagerlin A (2016) Am J Kidney Dis 67: 1-4 Long-term efficacy and safety of ezetimibe/simvastatin coadministered with extended-release niacin in hyperlipidaemic patients with diabetes or metabolic syndrome. Fazio S, Guyton JR, Lin J, Tomassini JE, Shah A, Tershakovec AM (2010) Diabetes Obes Metab 12: 983-93 Ezetimibe in renal transplant patients with hyperlipidemia resistant to HMG-CoA reductase inhibitors. Langone AJ, Chuang P (2006) Transplantation 81: 804-7 Is Zetia a 'do nothing' drug? Lindsley CW (2008) Curr Top Med Chem 8: 434 Long-term safety and efficacy of triple combination ezetimibe/simvastatin plus extended-release niacin in patients with hyperlipidemia. Fazio S, Guyton JR, Polis AB, Adewale AJ, Tomassini JE, Ryan NW, Tershakovec AM (2010) Am J Cardiol 105: 487-94 Ezetimibe reduces low-density lipoprotein cholesterol (LDL-C) in renal transplant patients resistant to HMG-CoA reductase inhibitors. Chuang P, Langone AJ (2007) Am J Ther 14: 438-41
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.